“Update vision on COVID-19: Structure, immune pathogenesis, treatment and safety assessment”

被引：14
作者：
Agrahari R. [1 ]
Mohanty S. [2 ]
Vishwakarma K. [1 ]
Nayak S.K. [3 ]
Samantaray D. [2 ]
Mohapatra S. [1 ]
机构：
[1] Amity Institute of Microbial Technology, Amity University, Uttar-pradesh, Noida
[2] Department of Microbiology, CBSH, OUAT, Odisha, Bhubaneswar
[3] Department of Biotechnology, CET, Odisha, Bhubaneswar
来源：
Sensors International | 2021年 / 2卷
关键词：
Medication; Origin; Pathogenesis; Replication; SARS-CoV2;
D O I：
10.1016/j.sintl.2020.100073
中图分类号：
学科分类号：
摘要：
The on-going SARS-CoV-2 causing COVID-19 discovered in December 2019, is responsible for a global pandemic. The virus belongs to the group of enveloped viruses containing linear, non-segmented, single stranded, positive sense strand RNA as genetic material. Already six different strains Coronaviruses are being reported to infect humans, however the seventh one is genetically similar to the SARS Coronavirus and termed as SARS-CoV-2. Specific crucial macromolecules such as membrane, nuclear, spike and enveloped proteins including HE esterase are present in the virus that interact with ACE2, APN, NEU-5, 9SC2 moiety of humans plays significant role in occurrence and transmission of the devastating disease. This review article summarizes the structure, histopathology, transmission of novel Coronavirus, its symptoms with preventive measures & currently prescribed drugs. Though various drugs and therapy have been administrated or implemented to restrict COVID-19, however it is imperative to develop an antidote against SARS-CoV-2 by the scientific or research community to save life. © 2020 The Authors
引用
收藏
相关论文
共 54 条
  • [1] Benvenuto D., Giovanetti M., Ciccozzi A., Spoto S., Angeletti S., Ciccozzi M., The 2019-new coronavirus epidemic: evidence for virus evolution, J. Med. Virol., 92, pp. 455-459, (2020)
  • [2] Berger J.R., COVID-19 and the nervous system, J. Neurovirol., 26, pp. 143-148, (2020)
  • [3] Hui D.S., I Azhar E., Madani T.A., Ntoumi F., Kock R., Dar O., Et al., The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China, Int. J. Infect. Dis., 91, pp. 264-266, (2020)
  • [4] Sharma S., Kundu A., Basu S., Shetti N.P., Aminabhavi T.M., Indians vs.COVID-19: the scenario of mental health, Sensors Int, 1, (2020)
  • [5] Kabir M.H., Gani M.O., Mandal S., Ali Biswas M.H., Modeling the dispersal effect to reduce the infection of COVID-19 in Bangladesh, Sensors Int, 1, (2020)
  • [6] Shetti N.P., Srivastava R.K., Sharma S., Basu S., Aminabhavi T.M., Invasion of novel corona virus (COVID-19) in Indian territory, Sensors Int, 1, (2020)
  • [7] Ulybkin A., Rybka A., Kovtun K., Kutny V., Voyevodin V., Pudov A., Et al., Compton (prompt-response) neutron detectors: comparison of emitter materials through the nuclear transmutation model, Sensors Int, 1, (2020)
  • [8] Agarwal K.M., Mohapatra S., Sharma P., Sharma S., Bhatia D., Mishra A., Study and overview of the novel corona virus disease (COVID-19), Sensors Int, 1, (2020)
  • [9] Behera S., Rana G., Satapathy S., Mohanty M., Pradhan S., Panda M.K., Et al., Biosensors in diagnosing COVID-19 and recent development, Sensors Int, 1, (2020)
  • [10] Ghosh A., Nundy S., Mallick T.K., How India is dealing with COVID-19 pandemic, Sensors Int, 1, (2020)
123456